Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
February-2023 Volume 27 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2023 Volume 27 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes

  • Authors:
    • Naoto Uramaru
    • Azusa Kawashima
    • Makoto Osabe
    • Toshiyuki Higuchi
  • View Affiliations / Copyright

    Affiliations: Division of Pharmaceutical Health Biosciences, Nihon Pharmaceutical University, Saitama 362‑0806, Japan
    Copyright: © Uramaru et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 51
    |
    Published online on: January 11, 2023
       https://doi.org/10.3892/mmr.2023.12938
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Obesity is a serious medical condition worldwide, and a major risk factor for type 2 diabetes, metabolic syndrome, cancer and cardiovascular disease. In addition to changes in dietary habits and physical activity, consuming supplements to maintain good health and prevent obesity is important in modern society. Raspberry ketone (RK) is a natural phenolic ketone found in the European red raspberry (Rubus idaeus L.) and is hypothesized to prevent obesity when administered orally. The present study found that RK was reduced to rhododendrol (ROH) in human liver microsomes and cytosol. The present study investigated whether the metabolite ROH had anti‑adipogenic effects using mouse 3T3‑L1 cells. The effects of ROH or RK on lipid accumulation during differentiation of 3T3‑L1 pre‑adipocyte into adipocyte were determined using Oil Red O staining. CCAAT enhancer‑binding protein α (C/EBPα) and peroxisome proliferator‑activated receptor γ (PPARγ) mRNA and protein expression were examined using reverse transcription‑quantitative PCR and western blotting analysis, respectively. The present study revealed that ROH suppressed lipid accumulation in the cells, similar to RK. In addition, ROH suppressed the mRNA expression levels of C/EBPα and PPARγ in 3T3‑L1 adipocytes. Furthermore, ROH suppressed PPARγ protein expression in 3T3‑L1 adipocytes. These findings suggested that ROH is an active metabolite with an anti‑adipogenic effect, which may contribute to the anti‑obesity effect of orally administered RK. The present study indicated that it is important to understand the biological activity of the metabolites of orally administered compounds.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Ding J, Reynolds LM, Zeller T, Müller C, Lohman K, Nicklas BJ, Kritchevsky SB, Huang Z, de la Fuente A, Soranzo N, et al: Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease. Diabetes. 64:3464–3474. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Kopelman PG: Obesity as a medical problem. Nature. 404:635–643. 2000. View Article : Google Scholar : PubMed/NCBI

3 

Garg SK, Maurer H, Reed K and Selagamsetty R: Diabetes and cancer: Two diseases with obesity as a common risk factor. Diabetes Obes Metab. 16:97–110. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Cao Z, Umek RM and McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538–1552. 1991. View Article : Google Scholar : PubMed/NCBI

5 

Farmer SR: Transcriptional control of adipocyte formation. Cell Metab. 4:263–273. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Morrison S and McGee SL: 3T3-L1 adipocytes display phenotypic characteristics of multiple adipocyte lineages. Adipocyte. 4:295–302. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Kim EJ, Kang MJ, Seo YB, Nam SW and Kim GD: Acer okamotoanum Nakai leaf extract inhibits adipogenesis via suppressing expression of PPAR γ and C/EBP α in 3T3-L1 cells. J Microbiol Biotechnol. 28:1645–1653. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Lee MS, Kim CT, Kim IH and Kim Y: Inhibitory effects of green tea catechin on the lipid accumulation in 3T3-L1 adipocytes. Phytother Res. 23:1088–1091. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Gallois A: Quantitative evaluation of raspberry ketone using thin-layer chromatography. Sci Aliments. 2:99–106. 1982.

10 

Larsen M, Poll L, Callesen O and Lewis M: Relations between the content of aroma compounds and the sensory evaluation of 10 raspberry varieties (Rubus idaeus L). Acta Agric Scand. 41:447–454. 1991. View Article : Google Scholar

11 

Mehanna ET, Barakat BM, El Sayed MH and Tawfik MK: An optimized dose of raspberry ketone controls hyperlipidemia and insulin resistance in male obese rats; Effect on adipose tissue expression of adipocytokines and aquaporin 7. Eur J Pharmacol. 832:81–89. 2018. View Article : Google Scholar : PubMed/NCBI

12 

Wang L, Meng X and Zhang F: Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis. J Med Food. 15:495–503. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Morimoto C, Satoh Y, Hara M, Inoue S, Tsujita T and Okuda H: Anti-obese action of raspberry ketone. Life Sci. 77:194–204. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Fuchino H, Konishi S, Satoh T, Yagi A, Saitsu K, Tatsumi T and Tanaka N: Chemical evaluation of Betula species in Japan. II. Constituents of Betula platyphylla var japonica. Chem Pharm Bull. 44:1033–1038. 1996. View Article : Google Scholar

15 

Inoue T, Ishidate Y, Fujita M, Kubo M, Fukushima M and Nagai M: Studies on the constituents of Aceraceae plants. I. Constituents in the leaves and the stem bark of Acer nikoense Maxim (author's transl). Yakugaku Zasshi. 98:41–46. 1978.(In Japanese). View Article : Google Scholar : PubMed/NCBI

16 

Li X, Wei T, Wu M, Chen F, Zhang P, Deng ZY and Luo T: Potential metabolic activities of raspberry ketone. J Food Biochem. 46:e140182022.PubMed/NCBI

17 

Sporstøl S and Scheline RR: The metabolism of 4-(4-hydroxyphenyl)butan-2-one (raspberry ketone) in rats, guinea-pigs and rabbits. Xenobiotica. 12:249–257. 1982. View Article : Google Scholar : PubMed/NCBI

18 

Tanaka Y, Nishikawa Y, Matsuda K, Yamazaki M and Hayashi R: Purification and some properties of ketone reductase forming an active metabolite of sodium 2-[4-(2-oxocyclopentylmethyl)-phenyl]propionate dihydrate (loxoprofen sodium), a new anti-inflammatory agent, in rabbit liver cytosol. Chem Pharm Bull (Tokyo). 32:1040–1048. 1984. View Article : Google Scholar : PubMed/NCBI

19 

Sasaki K, Yamauchi K and Kuwano S: Metabolic activation of sennoside A in mice. Planta Med. 37:370–378. 1979. View Article : Google Scholar : PubMed/NCBI

20 

Murata H, Higuchi T and Otagiri M: Oral pharmacokinetics and in-vitro metabolism of metyrapone in male rats. J Pharm Pharmacol. 68:970–979. 2016. View Article : Google Scholar : PubMed/NCBI

21 

Imamura Y, Iwamoto K, Yanachi Y, Higuchi T and Otagiri M: Postnatal development, sex-related difference and hormonal regulation of acetohexamide reductase activities in rat liver and kidney. J Pharmacol Exp Ther. 264:166–171. 1993.PubMed/NCBI

22 

Higuchi T, Imamura Y and Otagiri M: Kinetic studies on the reduction of acetohexamide catalyzed by carbonyl reductase from rabbit kidney. Biochim Biophys Acta. 1158:23–28. 1993. View Article : Google Scholar : PubMed/NCBI

23 

Imamura Y, Nozaki Y, Higuchi T and Otagiri M: Reactivity for prostaglandins and inhibition by nonsteroidal anti-inflammatory drugs of rabbit liver Befunolol reductase. Res Commun Chem Pathol Pharmacol. 71:49–57. 1991.PubMed/NCBI

24 

Zhao D, Yuan B, Kshatriya D, Polyak A, Simon JE, Bello NT and Wu Q: Influence of diet-induced obesity on the bioavailability and metabolism of raspberry ketone (4-(4-hydroxyphenyl)-2-butanone) in mice. Mol Nutr Food Res. 64:e19009072020. View Article : Google Scholar : PubMed/NCBI

25 

Kitayama T, Isomori S and Nakamura K: Asymmetric synthesis of enantiomerically pure zingerols by lipase-catalyzed transesterification and efficient synthesis of their analogues. Tetrahedron Asymmetry. 24:621–627. 2013. View Article : Google Scholar

26 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem. 150:76–85. 1985. View Article : Google Scholar : PubMed/NCBI

28 

Leu SY, Chen YC, Tsai YC, Hung YW, Hsu CH, Lee YM and Cheng PY: Raspberry ketone reduced lipid accumulation in 3T3-L1 cells and ovariectomy-induced obesity in Wistar rats by regulating autophagy mechanisms. J Agric Food Chem. 65:10907–10914. 2017. View Article : Google Scholar : PubMed/NCBI

29 

Tsai YC, Chen JH, Lee YM, Yen MH and Cheng PY: Raspberry ketone promotes FNDC5 protein expression via HO-1 upregulation in 3T3-L1 adipocytes. Chin J Physiol. 65:80–86. 2022. View Article : Google Scholar : PubMed/NCBI

30 

Park KS: Raspberry ketone increases both lipolysis and fatty acid oxidation in 3T3-L1 adipocytes. Planta Med. 76:1654–1658. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Park KS: Raspberry ketone, a naturally occurring phenolic compound, inhibits adipogenic and lipogenic gene expression in 3T3-L1 adipocytes. Pharm Biol. 53:870–875. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI

33 

Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543–546. 1995. View Article : Google Scholar : PubMed/NCBI

34 

Malátková P, Sokolová S, Chocholoušová Havlíková LC and Wsól V: Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases. Biochem Pharmacol. 109:83–90. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Matsumoto K, Hasegawa T, Koyanagi J, Takahashi T, Akimoto M and Sugibayashi K: Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: Exploratory prediction using inhibitors and substrates as marker probes. Eur J Drug Metab Pharmacokinet. 40:127–135. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Arent SM, Walker AJ, Pellegrino JK, Sanders DJ, McFadden BA, Ziegenfuss TN and Lopez HL: The combined effects of exercise, diet, and a multi-ingredient dietary supplement on body composition and adipokine changes in overweight Adults. J Am Coll Nutr. 37:111–120. 2018. View Article : Google Scholar : PubMed/NCBI

37 

White UA and Stephens JM: Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol. 318:10–14. 2010. View Article : Google Scholar : PubMed/NCBI

38 

Zhang BB, Zhou G and Li C: AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9:407–416. 2009. View Article : Google Scholar : PubMed/NCBI

39 

Ceddia RB: The role of AMP-activated protein kinase in regulating white adipose tissue metabolism. Mol Cell Endocrinol. 366:194–203. 2013. View Article : Google Scholar : PubMed/NCBI

40 

Piao GC, Liu GC, Jin XJ, Jin D and Yuan HD: Tetrahydropalmatine inhibits lipid accumulation through AMPK signaling pathway in 3T3-L1 adipocytes. Mol Med Rep. 15:3912–3918. 2017. View Article : Google Scholar : PubMed/NCBI

41 

Wang G, Wu B, Xu W, Jin X, Wang K and Wang H: The inhibitory effects of Juglanin on adipogenesis in 3T3-L1 adipocytes. Drug Des Dev Ther. 14:5349–5357. 2020. View Article : Google Scholar : PubMed/NCBI

42 

Jefcoate CR, Wang S and Liu X: Methods that resolve different contributions of clonal expansion to adipogenesis in 3T3-L1 and C3H10T1/2 cells. Methods Mol Biol. 456:173–193. 2008. View Article : Google Scholar : PubMed/NCBI

43 

Lee MS, Kim CT, Kim IH and Kim Y: Effects of capsaicin on lipid catabolism in 3T3-L1 adipocytes. Phytother Res. 25:935–939. 2011. View Article : Google Scholar : PubMed/NCBI

44 

Tzeng TF and Liu IM: 6-gingerol prevents adipogenesis and the accumulation of cytoplasmic lipid droplets in 3T3-L1 cells. Phytomedicine. 20:481–487. 2013. View Article : Google Scholar : PubMed/NCBI

45 

Guo LX, Chen G, Yin ZY, Zhang YH and Zheng XX: p-Synephrine exhibits anti-adipogenic activity by activating the Akt/GSK3β signaling pathway in 3T3-L1 adipocytes. J Food Biochem. 43:e130332019. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Uramaru N, Kawashima A, Osabe M and Higuchi T: Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes. Mol Med Rep 27: 51, 2023.
APA
Uramaru, N., Kawashima, A., Osabe, M., & Higuchi, T. (2023). Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes. Molecular Medicine Reports, 27, 51. https://doi.org/10.3892/mmr.2023.12938
MLA
Uramaru, N., Kawashima, A., Osabe, M., Higuchi, T."Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes". Molecular Medicine Reports 27.2 (2023): 51.
Chicago
Uramaru, N., Kawashima, A., Osabe, M., Higuchi, T."Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes". Molecular Medicine Reports 27, no. 2 (2023): 51. https://doi.org/10.3892/mmr.2023.12938
Copy and paste a formatted citation
x
Spandidos Publications style
Uramaru N, Kawashima A, Osabe M and Higuchi T: Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes. Mol Med Rep 27: 51, 2023.
APA
Uramaru, N., Kawashima, A., Osabe, M., & Higuchi, T. (2023). Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes. Molecular Medicine Reports, 27, 51. https://doi.org/10.3892/mmr.2023.12938
MLA
Uramaru, N., Kawashima, A., Osabe, M., Higuchi, T."Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes". Molecular Medicine Reports 27.2 (2023): 51.
Chicago
Uramaru, N., Kawashima, A., Osabe, M., Higuchi, T."Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes". Molecular Medicine Reports 27, no. 2 (2023): 51. https://doi.org/10.3892/mmr.2023.12938
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team